TP53 Mutations R175H and R249S Are Rare in Indian Head and Neck Cancer Patients

被引:0
|
作者
Ghosh, Arjita [1 ,2 ]
Moorthy, Anbalagan [1 ]
机构
[1] Vellore Inst Technol, Sch Biosci & Technol SBST, Dept Integrat Biol, Vellore, Tamil Nadu, India
[2] Vellore Inst Technol, Sch Biosci & Technol SBST, Dept Integrat Biol, Vellore 632014, Tamil Nadu, India
关键词
head and neck cancer; mutations; TP53; polymerase chain reaction coupled restriction fragment length polymorphism; R175H; R249S; SQUAMOUS-CELL CARCINOMA; P53; GENE;
D O I
10.1055/s-0043-1774776
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Mutations in tumor suppressor gene TP53 are considered as one of the main causes for different types of cancer. Head and neck squamous cell carcinoma (HNSCC) is one of the common cancers found in India. Among the several mutations reported in the TP53 gene, R175H and R249S are linked to cause of several cancers. This work was carried out to study the prevalence of R175H and R249S mutations in HNSCC patients of Indian origin.Method Tumor samples were collected from 50 HNSCC patients and good quality genomic deoxyribonucleic acid (DNA) were obtained from 41 samples. Using this genomic DNA, polymerase chain reaction-linked restriction fragment length polymorphism technique was used to screen both the mutations in the TP53 gene of the patients.Result The results revealed that out of the 41 samples analyzed, all the samples were negative for the mutations both in homozygous and heterozygous condition. This experiment was repeated three times, and the representative image is shown.Conclusion This study suggests that mutations in codon 175 (R175H) and 249 (R249S) are rare in HNSCC patients of Indian origin.
引用
收藏
页码:74 / 79
页数:6
相关论文
共 50 条
  • [41] A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells
    Alessia Garufi
    Daniela Trisciuoglio
    Manuela Porru
    Carlo Leonetti
    Antonella Stoppacciaro
    Valerio D’Orazi
    Maria Laura Avantaggiati
    Alessandra Crispini
    Daniela Pucci
    Gabriella D’Orazi
    Journal of Experimental & Clinical Cancer Research, 32
  • [42] A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells
    Garufi, Alessia
    Trisciuoglio, Daniela
    Porru, Manuela
    Leonetti, Carlo
    Stoppacciaro, Antonella
    D'Orazi, Valerio
    Avantaggiati, Maria Laura
    Crispini, Alessandra
    Pucci, Daniela
    D'Orazi, Gabriella
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
  • [43] Rate of TP53 mutations in HPV-positive (HPV+) recurrent/metastatic head and neck cancer (RMHNC) patients.
    Thach, Dzung
    Ahmad, Moin
    Penta, Adrienne L.
    Sulkowski, Gisela N.
    Kallakury, Bhaskar
    Chahine, Joeffrey J.
    Niederhuber, John E.
    Iyer, Ramaswamy K.
    Deeken, John F.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Nucleotide variants and protein expression of TP53 in a Sri Lankan cohort of patients with head and neck cancer
    Manoharan, Vahinipriya
    Karunanayake, Eric Hamilton
    Tennekoon, Kamani Hemamala
    De Silva, Sumadee
    De Silva, Kanishka
    Angunawela, Preethika
    Lunec, John
    MOLECULAR MEDICINE REPORTS, 2019, 19 (04) : 2781 - 2791
  • [45] R337H mutation of the TP53 gene as a clinical marker in cancer patients: a systematic review of literature
    Borges, L. M.
    Ayres, F. M.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 17034 - 17043
  • [46] Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patients
    Shi, Qi
    Xiao, Kang
    Wei, Wei
    Zhang, Bao-Yun
    Chen, Cao
    Xu, Yin
    Chen, Li-Na
    Song, Yun-Tao
    Ma, Xiao
    Zhang, Nai-Song
    Dong, Xiao-Ping
    ONCOLOGY REPORTS, 2013, 30 (06) : 2811 - 2819
  • [47] Association of the germline TP53 R337H mutation with breast cancer in southern Brazil
    Assumpcao, Juliana G.
    Seidinger, Ana Luiza
    Mastellaro, Maria Jose
    Ribeiro, Raul C.
    Zambetti, Gerard P.
    Ganti, Ramapriya
    Srivastava, Kumar
    Shurtleff, Sheila
    Pei, Deqing
    Zeferino, Luiz Carlos
    Dufloth, Rozany M.
    Brandalise, Silvia Regina
    Yunes, Jose Andres
    BMC CANCER, 2008, 8 (1)
  • [48] Oncogene c-fos and mutant R175H p53 regulate expression of Nucleophosmin implicating cancer manifestation
    Senapati, Parijat
    Dey, Suchismita
    Sudarshan, Deepthi
    Das, Sadhan
    Kumar, Manoj
    Kaypee, Stephanie
    Mohiyuddin, Azeem
    Kodaganur, Gopinath S.
    Kundu, Tapas K.
    FEBS JOURNAL, 2018, 285 (18) : 3503 - 3524
  • [49] Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients
    Osman, Abdullah A.
    Neskey, David M.
    Katsonis, Panagiotis
    Patel, Ameeta A.
    Ward, Alexandra M.
    Hsu, Teng-Kuei
    Hicks, Stephanie C.
    McDonald, Thomas O.
    Ow, Thomas J.
    Alves, Marcus Ortega
    Pickering, Curtis R.
    Skinner, Heath D.
    Zhao, Mei
    Sturgis, Eric M.
    Kies, Merrill S.
    El-Naggar, Adel
    Perrone, Federica
    Licitra, Lisa
    Bossi, Paolo
    Kimmel, Marek
    Frederick, Mitchell J.
    Lichtarge, Olivier
    Myers, Jeffrey N.
    CANCER RESEARCH, 2015, 75 (07) : 1205 - 1215
  • [50] Analysis of mutational variations in TP53 tumour suppressor gene among Pakistani head and neck cancer patients
    Fatima, Summera
    Bibi, Asia
    Qureshi, Sara Samad
    Khan, Suman
    ECANCERMEDICALSCIENCE, 2024, 18